Nguyen T T, Shou I, Funabiki K, Shirato I, Kubota K, Tomino Y
Division of Nephrology, Department of Medicine, Juntendo University School of Medicine, Tokyo, Japan.
Am J Nephrol. 1999;19(4):495-9. doi: 10.1159/000013505.
The purpose of the present study was to evaluate the correlations among expression of intercellular adhesion molecule 1 (ICAM-1) in glomeruli, levels of soluble ICAM-1 (sICAM-1) in sera, and renal injuries in patients with IgA nephropathy. The levels of sICAM-1 in sera from 27 patients with IgA nephropathy and 7 healthy controls were measured by the human soluble ICAM-1 immunoassay. The expression of ICAM-1 in glomeruli was detected by indirect immunofluorescence. We observed marked expression of ICAM-1 in glomerular capillary walls and mesangial areas in patients with advanced-stage, but not in those with mild IgA nephropathy. Since the histopathological changes in the advanced stage of this disease were characterized by diffuse mesangial cell proliferation and tubulointerstitial injury, the expression of ICAM-1 in the glomeruli may be of value in evaluating the degree of renal lesions in patients with IgA nephropathy. However, there was no significant change in the levels of serum sICAM-1 among mild-stage and advanced-stage patients and healthy controls. It appears that the measurement of serum sICAM-1 is not useful in evaluating the degree of renal injuries in patients with IgA nephropathy.
本研究的目的是评估IgA肾病患者肾小球中细胞间黏附分子1(ICAM-1)的表达、血清中可溶性ICAM-1(sICAM-1)水平与肾损伤之间的相关性。采用人可溶性ICAM-1免疫测定法检测27例IgA肾病患者和7例健康对照者血清中的sICAM-1水平。通过间接免疫荧光法检测肾小球中ICAM-1的表达。我们观察到,晚期IgA肾病患者肾小球毛细血管壁和系膜区有明显的ICAM-1表达,而轻度IgA肾病患者则无。由于该疾病晚期的组织病理学变化以弥漫性系膜细胞增生和肾小管间质损伤为特征,肾小球中ICAM-1的表达可能对评估IgA肾病患者的肾损伤程度有价值。然而,轻度和晚期患者以及健康对照者血清sICAM-1水平无显著变化。看来,检测血清sICAM-1对评估IgA肾病患者的肾损伤程度并无帮助。